Frequency, risk factors, and outcomes of hospital readmissions of COVID-19 patients.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
02 07 2021
Historique:
received: 17 10 2020
accepted: 10 06 2021
entrez: 3 7 2021
pubmed: 4 7 2021
medline: 16 7 2021
Statut: epublish

Résumé

To determine the proportion of patients with COVID-19 who were readmitted to the hospital and the most common causes and the factors associated with readmission. Multicenter nationwide cohort study in Spain. Patients included in the study were admitted to 147 hospitals from March 1 to April 30, 2020. Readmission was defined as a new hospital admission during the 30 days after discharge. Emergency department visits after discharge were not considered readmission. During the study period 8392 patients were admitted to hospitals participating in the SEMI-COVID-19 network. 298 patients (4.2%) out of 7137 patients were readmitted after being discharged. 1541 (17.7%) died during the index admission and 35 died during hospital readmission (11.7%, p = 0.007). The median time from discharge to readmission was 7 days (IQR 3-15 days). The most frequent causes of hospital readmission were worsening of previous pneumonia (54%), bacterial infection (13%), venous thromboembolism (5%), and heart failure (5%). Age [odds ratio (OR): 1.02; 95% confident interval (95% CI): 1.01-1.03], age-adjusted Charlson comorbidity index score (OR: 1.13; 95% CI: 1.06-1.21), chronic obstructive pulmonary disease (OR: 1.84; 95% CI: 1.26-2.69), asthma (OR: 1.52; 95% CI: 1.04-2.22), hemoglobin level at admission (OR: 0.92; 95% CI: 0.86-0.99), ground-glass opacification at admission (OR: 0.86; 95% CI:0.76-0.98) and glucocorticoid treatment (OR: 1.29; 95% CI: 1.00-1.66) were independently associated with hospital readmission. The rate of readmission after hospital discharge for COVID-19 was low. Advanced age and comorbidity were associated with increased risk of readmission.

Identifiants

pubmed: 34215803
doi: 10.1038/s41598-021-93076-0
pii: 10.1038/s41598-021-93076-0
pmc: PMC8253752
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

13733

Références

Chron Respir Dis. 2019 Jan-Dec;16:1479972318809480
pubmed: 30428701
Eur J Case Rep Intern Med. 2020 Apr 08;7(5):001646
pubmed: 32399449
Thromb Res. 2020 Jul;191:148-150
pubmed: 32381264
J Intern Med. 2021 Jul;290(1):157-165
pubmed: 33452824
Appl Clin Inform. 2020 Oct;11(5):792-801
pubmed: 33241547
Euro Surveill. 2020 Dec;25(50):
pubmed: 33334400
Radiologia (Engl Ed). 2021 Jan-Feb;63(1):56-73
pubmed: 33339622
Eur J Intern Med. 2012 Jul;23(5):451-6
pubmed: 22726375
BMC Infect Dis. 2020 Nov 10;20(1):818
pubmed: 33167900
Lancet. 2021 Feb 13;397(10274):605-612
pubmed: 33545096
N Engl J Med. 2020 Nov 19;383(21):2041-2052
pubmed: 32706953
Oncologist. 2020 Jun;25(6):e936-e945
pubmed: 32243668
Healthc (Amst). 2021 Mar;9(1):100512
pubmed: 33383393
PLoS One. 2021 Mar 16;16(3):e0248358
pubmed: 33725003
Clin Infect Dis. 2021 Feb 16;72(4):652-660
pubmed: 32649738
Int J Infect Dis. 2020 Sep;98:84-89
pubmed: 32553714
CMAJ. 2021 Mar 22;193(12):E410-E418
pubmed: 33568436
J Med Virol. 2020 Nov;92(11):2263-2265
pubmed: 32492212
QJM. 2020 Sep 1;113(9):657-665
pubmed: 32442308
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Rev Clin Esp. 2020 Nov;220(8):480-494
pubmed: 33994573
Infect Control Hosp Epidemiol. 2020 Aug;41(8):982-983
pubmed: 32279676
Int J Infect Dis. 2021 Apr;105:374-376
pubmed: 33684560
J Stroke Cerebrovasc Dis. 2020 Jul;29(7):104881
pubmed: 32334918
Ann Transl Med. 2020 May;8(10):635
pubmed: 32566572
Ann Intern Med. 2021 Apr;174(4):576-578
pubmed: 33175566
Dig Dis Sci. 2020 Aug;65(8):2181-2186
pubmed: 32537704
J Hosp Med. 2019 Apr;14(4):201-206
pubmed: 30933669
J Gen Intern Med. 2020 Oct;35(10):2838-2844
pubmed: 32815060
Health Syst Transit. 2018 May;20(2):1-179
pubmed: 30277216
Euro Surveill. 2020 Jul;25(26):
pubmed: 32643600
MMWR Morb Mortal Wkly Rep. 2020 Nov 13;69(45):1695-1699
pubmed: 33180754
EClinicalMedicine. 2020 Aug;25:100449
pubmed: 32838231

Auteurs

Antonio Ramos-Martínez (A)

Infectious Diseases Unit, Internal Medicine Department, Hospital Universitario Puerta de Hierro-Majadahonda UAM, IDIPHSA, Maestro Rodrigo 2, 28222, Majadahonda, Madrid, Spain. aramos220@gmail.com.
Infectious Diseases Unit, Hospital Universitario Puerte de Hierro-Majadahonda Majadahonda, Calle Maestro Rodrigo 2, 28222, Majadahonda, Madrid, Spain. aramos220@gmail.com.

Lina Marcela Parra-Ramírez (LM)

Preventive Medicine Department, Hospital Universitario Puerta de Hierro-Majadahonda UAM, IDIPHSA, Maestro Rodrigo 2, 28222, Majadahonda, Madrid, Spain.

Ignacio Morrás (I)

Internal Medicine Department, Hospital Universitario Puerta de Hierro-Majadahonda UAM, IDIPHSA, Maestro Rodrigo 2, 28222, Majadahonda, Madrid, Spain.

María Carnevali (M)

Internal Medicine Department, 12 de Octubre University Hospital, Av. de Córdoba, s/n, 28041, Madrid, Spain.

Lorena Jiménez-Ibañez (L)

Internal Medicine Department, Gregorio Marañon University Hospital, Dr. Esquerdo, 46, 28007, Madrid, Spain.

Manuel Rubio-Rivas (M)

Internal Medicine Department, Bellvitge University Hospital, Carrer de La Feixa Llarga, s/n, 08907, L'Hospitalet de Llobregat, Barcelona, Spain.

Francisco Arnalich (F)

Internal Medicine Department, La Paz University Hospital, Paseo de La Castellana, 261, 28046, Madrid, Spain.

José Luis Beato (JL)

Internal Medicine Department, Albacete University Hospital Complex, Hermanos Falco, 37, 02006, Albacete, Spain.

Daniel Monge (D)

Internal Medicine Department, Segovia Hospital Complex, Luis Erik Clavería Neurólogo s/n, 40002, Segovia, Spain.

Uxua Asín (U)

Internal Medicine Department, Miguel Servet Hospital, Paseo Isabel la Católica, 1-3, 50009, Zaragoza, Spain.

Carmen Suárez (C)

Internal Medicine Department, La Princesa University Hospital, Diego de León, 62, 28006, Madrid, Spain.

Santiago Jesús Freire (SJ)

Internal Medicine Department, A Coruña University Hospital, Xubias de Arriba, 84, 15006 A, Coruña, Spain.

Manuel Méndez-Bailón (M)

Internal Medicine Department, San Carlos Clinical Hospital, Prof Martín Lagos, s/n, 28040, Madrid, Spain.

Isabel Perales (I)

Internal Medicine Department, Infanta Sofía Hospital, Paseo de Europa, 34, 28703, San Sebastián de los Reyes, Madrid, Spain.

José Loureiro-Amigo (J)

Internal Medicine Department, Moisès Broggi Hospital, Carrer de Jacint Verdaguer, 90, 08970, Sant Joan Despí, Barcelona, Spain.

Ana Belén Gómez-Belda (AB)

Internal Medicine Department, Dr. Peset University Hospital, Av. de Gaspar Aguilar, 90, 46017, Valencia, Spain.

Paula María Pesqueira (PM)

Internal Medicine Department, Santiago Clinical Hospital, Rúa da Choupana, s/n, 15706, Santiago de Compostela, A Coruña, Spain.

Ricardo Gómez-Huelgas (R)

Internal Medicine Department, Regional University Hospital of Málaga, Biomedical Research Institute of Málaga (IBIMA), University of Málaga (UMA), Av. de Carlos Haya, 84, 29010, Málaga, Spain.

Carmen Mella (C)

Internal Medicine Department, Hospital Architect Marcide-Novoa Santos, Rúa Pardo Bazán, s/n, 15404, Ferrol, A Coruña, Spain.

Luis Felipe Díez-García (LF)

Internal Medicine Department, Torrecárdenas Hospital, Hermandad de Donantes de Sangre, s/n, 04009, Almería, Spain.

Joaquim Fernández-Sola (J)

Internal Medicine Department, Clinic Barcelona Hospital, Villarroel, 170, 08036, Barcelona, Spain.

Ruth González-Ferrer (R)

Internal Medicine Department, Tajo Hospital, Av. Amazonas Central, s/n, 28300, Aranjuez, Madrid, Spain.

Marina Aroza (M)

Internal Medicine Department, Insular de Gran Canaria Hospital, Av. Marítima del Sur, s/n, 35016, Las Palmas de Gran Canaria, Las Palmas, Spain.

Juan Miguel Antón-Santos (JM)

Internal Medicine Department, Infanta Cristina University Hospital, Av. 9 de Junio, 2, 28981, Parla, Madrid, Spain.

Carlos Lumbreras Bermejo (CL)

Internal Medicine Department, 12 de Octubre University Hospital, Av. de Córdoba, s/n, 28041, Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH